People

Photo
10.02.2023 • News

Bill Anderson to Be Bayer CEO from June 1

Bowing to growing pressure from activist investors with different missions, the supervisory board of tradition-steeped German pharmaceuticals and agrochemicals player Bayer has announced the appointment of a new CEO to succeed embattled incumbent Werner Baumann — a year before the end of the current chief executive’s regular term.

Photo
30.09.2022 • News

GSK Names Julie Brown as First Female CFO

From next year, GSK’s top management will be led by a double female team, a pioneering move for the global pharmaceutical industry. The UK drugs giant this week announced the appointment of Julie Brown, the first woman to be its chief financial officer.

Photo
19.09.2022 • News

Calum MacLean to Head Lanxess-Advent JV

German specialty chemicals producer Lanxess and private equity group Advent International have named Calum MacLean as CEO-designate of their planned joint venture for high-performance engineering plastics.

Photo
31.03.2022 • News

Yann Lissillour Appointed CEO of Safic-Alcan

Martial Lecat and Philippe Combette will cease their functions within the Safic-Alcan Executive Committee on Apr. 1, 2022. At the same time, Combette, current Chairman of Safic-Alcan, will hand over the presidency of the group to Yann Lissillour. Lectat and Combette joined Safic-Alcan in June and October 1988 respectively.

Photo
12.01.2022 • News

Gelest Names Jonathan Goff as President

US chemicals and materials group Gelest has named Jonathan Goff as President effective immediately. He succeeds Barry Arkles, founder of Gelest, who has officially stepped down from his role as CEO on Dec. 31, 2021.

Photo
02.12.2021 • News

GSK Lures Pfizer’s Vaccines R&D Chief Away

Britain’s largest drugmaker, GlaxoSmithKline (GSK) has landed a major coup, luring Pfizer’s vaccines R&D chief away, as it tries to regain its position in the top tier of the vaccine league and build up its presence in the mRNA field. On Dec. 3, Philip Dormitzer, who had served as the US pharma giant’s chief scientific officer for RNA and viral vaccines since 2015, will say goodbye to New York and, figuratively, at least, hello to London.

Photo
17.02.2021 • News

PolyPeptide Group Appoints Raymond De Vré as new CEO

PolyPeptide Group has appointed Raymond De Vré as its new Chief Executive Officer (CEO). He will succeed Jane Salik who, after 15 years in this position, will concentrate on her role on the Board of Directors.

462 more articles

Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.